The hottest pharmaceutical packaging industry in C

2022-08-21
  • Detail

China's pharmaceutical packaging industry will present a new situation

with the reform of China's medical system, the disordered and backward situation of pharmaceutical packaging will fundamentally change. At present, China is constantly introducing and updating pharmaceutical packaging machinery and materials, and the pharmaceutical packaging industry will present a new situation. The diversification of drug types also brings diversification to the forms of pharmaceutical packaging. In recent years, the packaging of solid drugs in China, such as plain tablets, capsules, injections and externally applied drugs, has been updated rapidly. At the same time, the use of disposable plastic syringes has brought a major change to the packaging and application of injections in China. 2. It is a continuation of refinement and the introduction of relevant industrial support policies, The improvement direction of large infusion packaging is also moving towards the direction of composite flexible packaging bags and plastic bottle packaging

the "analysis report on the prosperity of China's pharmaceutical industry in the second quarter of 2003" jointly launched by the Economic Research Institute of the national development and Reform Commission and Beijing Xinhua Information Technology Co., Ltd. shows that affected by SARS, medicine became the first in the production growth of various industries in the second quarter of this year. In January this year, the pharmaceutical industry achieved a total industrial output value of 143.362 billion yuan (at current prices), an increase of 21.55% over the same period last year; According to the statistics of constant prices, the total output value of the pharmaceutical industry was 183.09 billion yuan, an increase of 24.82%. In a word, looking at the prospects of China's pharmaceutical development in the next few years, we can predict the rapid development of China's pharmaceutical packaging in the future

according to the report of the American flexible packaging Association, by 2003, the demand for basic packaging of pharmaceutical products in the world will increase by 4.2%, and the total output value will reach US $11.2 billion. In the next five years, the pharmaceutical packaging industry will become the second largest economic growth point of the flexible packaging industry. To seize this opportunity, experts believe that China's pharmaceutical packaging should do the following: first, accelerate the promotion and application of plastic containers for pharmaceutical oral liquids; Second, to speed up the development of plastic hollow container packaging of traditional Chinese medicine, we should use more plastic hollow containers made of HDPE, PP, pet, pen and other materials and using injection blow molding and other molding processes. The mouth of the hollow container is sealed with aluminum foil electromagnetic induction gasket to enhance the safety protection of drugs, and speed up the promotion and application of plastic composite membrane bag packaging of traditional Chinese medicine

it should be said that in the next few years, medical packaging will have a lot of acceleration in the elimination of HCFCs and the replacement of bromine flame retardants. 6. Packaging and process performance experimental instruments (including packaging drop experimental instruments, packaging impact experimental instruments, friction and wear experimental instruments, bending experimental instruments, straightening machines, etc.); Development, with good prospects and large space. In the future, there will be more and more single dose packaging of drugs, and foreign pharmaceutical enterprises also began to pour into the Chinese market. How to seize this opportunity is worth thinking about for Chinese pharmaceutical packaging enterprises. Director Ji believes that first of all, we should strengthen the R & D capacity of enterprises and improve the grade of packaging materials. In the future, the trend of oligopoly of pharmaceutical enterprises will become more and more obvious, and their procurement will be collectivized, which is a severe challenge for packaging materials enterprises, which requires pharmaceutical packaging enterprises to have a long-term vision and implement a sustainable development strategy of going out; We should constantly innovate in new materials and products, have our own R & D team, have packaging products with independent property rights, and take the road of high-quality packaging and green packaging

Secretary General Chen of the packaging and Printing Committee of China Packaging Technology Association believes that although traditional Chinese medicine has a history of thousands of years, it has failed to enter the European and American markets on a large scale. In addition to the outdated production technology and some prejudice of European and American countries against traditional Chinese medicine, the failure of pharmaceutical packaging to implement national standards is also an important reason. The standard of traditional Chinese medicine (TCM) has been a barrier for TCM manufacturers to expand to overseas markets. From the perspective of the market, the culprit of the difficulty in exporting Chinese patent medicine is actually the problem of material selection rather than the packaging material itself. In this regard, Ji, director of Shanghai Institute of pharmaceutical packaging and testing, believes that it is wise to choose appropriate packaging materials according to the characteristics of drugs. At the same time, we should develop green packaging, protect the environment and promote the sustainable development of society. After China's accession to the WTO, tariff barriers have been gradually eliminated, but technical barriers and environmental barriers are gradually forming. How to grasp the future development trend is worthy of enterprises' attention

after China's entry into WTO, domestic pharmaceutical enterprises will actively participate in the competition in the international market. Secretary General Chen said that in order to eliminate the technical barriers caused by pharmaceutical packaging and other reasons, advanced packaging equipment and materials that meet international standards will be required to cooperate with its development, which also puts forward higher requirements and broader market space for domestic 6.3 pharmaceutical packaging enterprises such as extensometer. From the perspective of the enterprise itself, the packaging of drugs should be more concise, clear and beautiful. On the premise of ensuring that it is not easy to be damaged during transportation, materials should be saved as much as possible, and excessive packaging should not be allowed. The market competitiveness of the enterprise should be improved by continuously improving the quality of its employees. The national macro-control department should also speed up the legislative work of packaging, raise the technical threshold, and constantly guide the benign development of enterprises through macro-control

Copyright © 2011 JIN SHI